SMA News Today

Biogen is Planning to Launch a First Trial, Testing Spinraza in Children Previously Given Zolgensma

Biogen is Planning to Launch a First Trial, Testing Spinraza in Children Previously Given Zolgensma

SMA News Today’s multimedia associate, Price Wooldridge, discusses the news Biogen is planning to launch a first trial, testing Spinraza in children previously given Zolgensma. Are you interested in learning more about spinal muscular atrophy? If so, please visit https://smanewstoday.com/

Duration: 6 min

Release Date:

Share part or all of the audio of this episode